by Andreas Kremer | Jun 16, 2023
Luxembourg, June 14th 2023. Today a consortium of public and private entities announced the official launch of IDERHA (Integration of heterogenous Data and Evidence towards Regulatory & HTA Acceptance). The consortium aims to propel health care innovation in...
by Andreas Kremer | Sep 22, 2022
Development of COPD prognostic routine for optimal therapy prediction on the basis of lipid microbial biomarkers and AI-based modeling of immune response. The COPreDict project aims at providing COPD patients and their doctors with a full-cycle support product, which...
by Andreas Kremer | Jun 1, 2022
EU-PEARL is a strategic partnership between the public and private sectors to shape the future of clinical trials. This innovative and challenging enterprise aims to create a framework for patient-centric integrated research platform (IRP) trials, through which novel...
by Andreas Kremer | Nov 15, 2021
OPTIMA aims to harness the power of artificial intelligence, to advance treatments and facilitate decision-making for physicians and patients with prostate, breast and lung cancer. At the heart of OPTIMA will be Europe’s first interoperable, large scale oncology data...
by Lisa Blum | Feb 3, 2021
Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative novel treatment that has the potential to cure cancer. Multiple new versions of this therapy are being developed for distinct...
